Tianjin Medical University General Hospital

This study aimed to test whether eculizumab, a drug already approved to prevent NMOSD attacks, could also help treat acute attacks in adults with AQP4 antibodies. It was designed for people experiencing sudden optic nerve or spinal cord inflammation. However, the trial was withdr…

This study tests whether tocilizumab can safely prevent relapses in people with MOGAD, a rare autoimmune disease that attacks the nervous system. About 102 participants aged 12 and older with recent relapses will receive the drug or a placebo. The main goal is to see if the drug …